Nymox Pharmaceutical Corporation announced a private placement of 2,000,000 common shares at a price of $1.00 per share for gross proceeds of $2,000,000 on August 2, 2023. The company will also issue 500,000 warrants. The transaction included participation from James G. Robinson, an independent director of the company.

The investment will close in the upcoming days after the customary formalities are completed.